# Cost-Effectiveness of Canagliflozin versus Sitagliptin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus in Mexico

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-canagliflozin-versus-sitagliptin-as-add-on-to-metformin-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | C. Neslusan,Anna Teschemaker,Pierre Johansen,Michael Willis,Atanacio Valencia-Mendoza,Andrea Puig |
| Citations | 18 |
| DOI | 10.1016/j.vhri.2015.01.002 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.valuehealthregionalissues.com/article/S2212109915000035/pdf |
| OpenAlex ID | https://openalex.org/W1783870628 |
| PMID | 29698175 |
| Type | article |
| Year | 2015 |

## Paper authors

- [C. Neslusan](https://scholariq.org/researchers/c-neslusan/)

## Paper journal

- [Value in Health Regional Issues](https://scholariq.org/journals/value-in-health-regional-issues/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.